Medtronic EBITDA 2010-2025 | MDT

Medtronic annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Medtronic EBITDA for the quarter ending January 31, 2025 was $2.329B, a 9.24% increase year-over-year.
  • Medtronic EBITDA for the twelve months ending January 31, 2025 was $8.247B, a 1.01% decline year-over-year.
  • Medtronic 2024 annual EBITDA was $7.792B, a 4.77% decline from 2023.
  • Medtronic 2023 annual EBITDA was $8.182B, a 3.29% decline from 2022.
  • Medtronic 2022 annual EBITDA was $8.46B, a 17.73% increase from 2021.
Medtronic Annual EBITDA
(Millions of US $)
2024 $7,792
2023 $8,182
2022 $8,460
2021 $7,186
2020 $7,454
2019 $8,927
2018 $9,284
2017 $8,300
2016 $8,210
2015 $5,148
2014 $4,671
2013 $5,678
2012 $5,666
2011 $5,272
2010 $5,653
2009 $4,686
Medtronic Quarterly EBITDA
(Millions of US $)
2025-01-31 $2,329
2024-10-31 $2,269
2024-07-31 $1,942
2024-04-30 $1,707
2024-01-31 $2,132
2023-10-31 $2,012
2023-07-31 $1,941
2023-04-30 $2,246
2023-01-31 $2,070
2022-10-31 $2,074
2022-07-31 $1,792
2022-04-30 $2,360
2022-01-31 $2,331
2021-10-31 $2,239
2021-07-31 $1,530
2021-04-30 $2,288
2021-01-31 $1,955
2020-10-31 $1,601
2020-07-31 $1,342
2020-04-30 $988
2020-01-31 $2,302
2019-10-31 $2,022
2019-07-31 $2,142
2019-04-30 $2,613
2019-01-31 $2,217
2018-10-31 $2,195
2018-07-31 $1,902
2018-04-30 $2,592
2018-01-31 $2,102
2017-10-31 $2,572
2017-07-31 $2,018
2017-04-30 $2,381
2017-01-31 $1,884
2016-10-31 $2,124
2016-07-31 $1,911
2016-04-30 $2,290
2016-01-31 $2,077
2015-10-31 $2,004
2015-07-31 $1,839
2015-04-30 $843
2015-01-31 $1,550
2014-10-31 $1,401
2014-07-31 $1,354
2014-04-30 $522
2014-01-31 $1,241
2013-10-31 $1,421
2013-07-31 $1,487
2013-04-30 $1,435
2013-01-31 $1,455
2012-10-31 $1,408
2012-07-31 $1,380
2012-04-30 $1,437
2012-01-31 $1,383
2011-10-31 $1,455
2011-07-31 $1,391
2011-04-30 $1,236
2011-01-31 $1,380
2010-10-31 $1,347
2010-07-31 $1,309
2010-04-30 $1,304
2010-01-31 $1,502
2009-10-31 $1,449
2009-07-31 $1,398
2009-04-30 $877
2009-01-31 $1,188
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $109.157B $32.364B
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $224.526B 27.00
Boston Scientific (BSX) United States $152.309B 38.13
Stryker (SYK) United States $147.916B 30.93
EssilorLuxottica (ESLOY) France $129.703B 0.00
Lonza Group Ag (LZAGY) Switzerland $49.583B 0.00
Haleon (HLN) United Kingdom $47.109B 26.80
ResMed (RMD) United States $36.312B 27.27
GE HealthCare Technologies (GEHC) United States $33.806B 16.05
Agilent Technologies (A) United States $32.907B 21.74
Terumo (TRUMY) Japan $27.953B 0.00
Koninklijke Philips (PHG) Netherlands $22.765B 16.36
Insulet (PODD) United States $22.130B 86.87
Zimmer Biomet Holdings (ZBH) United States $19.288B 12.39
Baxter (BAX) United States $15.985B 11.94
Smith & Nephew SNATS (SNN) United Kingdom $12.381B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $7.091B 23.97
Lantheus Holdings (LNTH) United States $5.462B 13.78
Prestige Consumer Healthcare (PBH) United States $4.298B 19.20
Perrigo (PRGO) Ireland $3.605B 9.14
ICU Medical (ICUI) United States $3.534B 26.06
Haemonetics (HAE) United States $3.473B 15.13
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.154B 26.21
QuidelOrtho (QDEL) United States $2.401B 16.52
GN Store Nord (GNNDY) Denmark $2.164B 17.92
LeMaitre Vascular (LMAT) United States $1.882B 42.06
AtriCure (ATRC) United States $1.558B 0.00
Neogen (NEOG) United States $1.409B 18.03
AdaptHealth (AHCO) United States $1.217B 12.36
Kestra Medical Technologies (KMTS) United States $1.179B 0.00
Green Thumb Industries (GTBIF) United States $1.172B 26.35
BioLife Solutions (BLFS) United States $1.097B 0.00
InMode (INMD) Israel $1.038B 9.50
Phibro Animal Health (PAHC) United States $0.996B 12.75
Evolus (EOLS) United States $0.653B 0.00
CeriBell (CBLL) United States $0.600B 0.00
Curaleaf Holdings (CURLF) Canada $0.577B 0.00
Owens & Minor (OMI) United States $0.559B 4.63
Valneva SE (VALN) France $0.534B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.524B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Surmodics (SRDX) United States $0.398B 0.00
Cresco Labs (CRLBF) United States $0.350B 0.00
SNDL (SNDL) Canada $0.347B 0.00
Capricor Therapeutics (CAPR) United States $0.333B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Sanara MedTech (SMTI) United States $0.312B 0.00
VAREX IMAGING (VREX) United States $0.309B 11.36
Aurora Cannabis (ACB) Canada $0.290B 51.60
Sanuwave Health (SNWV) United States $0.285B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.97
Canopy Growth (CGC) Canada $0.267B 0.00
Omeros (OMER) United States $0.258B 0.00
Verano Holdings (VRNOF) United States $0.255B 0.00
Cerus (CERS) United States $0.250B 0.00
ZimVie (ZIMV) United States $0.248B 11.28
Biote (BTMD) United States $0.214B 6.02
OraSure Technologies (OSUR) United States $0.198B 0.00
High Tide (HITI) Canada $0.186B 0.00
Brainsway (BWAY) Israel $0.185B 49.05
Quanterix (QTRX) United States $0.180B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.47
Organigram Global (OGI) Canada $0.166B 0.00
TriSalus Life Sciences (TLSI) United States $0.164B 0.00
FitLife Brands (FTLF) United States $0.148B 18.19
Jin Medical (ZJYL) China $0.133B 0.00
Exagen (XGN) United States $0.120B 0.00
TerrAscend (TSNDF) Canada $0.116B 0.00
Agape ATP (ATPC) $0.101B 0.00
MacroGenics (MGNX) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Fonar (FONR) United States $0.077B 10.71
Veru (VERU) United States $0.076B 0.00
Quipt Home Medical (QIPT) United States $0.072B 0.00
InterCure (INCR) Israel $0.070B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
Zynex (ZYXI) United States $0.066B 0.00
United Health Products (UEEC) United States $0.061B 0.00
Apyx Medical (APYX) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.037B 12.94
Rockwell Medical (RMTI) United States $0.037B 0.00
Safety Shot (SHOT) United States $0.034B 0.00
Nephros (NEPH) United States $0.023B 0.00
INLIF (INLF) $0.020B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00